$2,180.75 travel Payment -- Merck & Co to Dr. Maria Martinez

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Merck & Co made a $2.2K travel payment to Maria Martinez, a Pulmonology specialist in Syracuse, NY. The payment was associated with Xtandi. The payment of $2,180.75 to Dr. Maria Martinez by Merck & Co. for travel and lodging related to Xtandi is a significant expense. This payment occurred on October 18, 2025, indicating a recent engagement between the pharma company and the physician. The travel and lodging were associated with Xtandi, a drug used in the treatment of prostate cancer, suggesting a focus on this therapeutic area.

Patient Guidance: What This Payment Means for You

If you received travel or lodging payments from a pharmaceutical company, ensure these expenses were for legitimate educational or research activities and not for personal benefit. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

While travel and lodging payments are common in the pharmaceutical industry, the amount of $2,180.75 for a pulmonologist in relation to Xtandi should be reviewed for appropriateness within industry norms for speaker programs, advisory boards, or research collaborations.

Regulatory Context: Sunshine Act Requirements

Payments for travel and lodging must be reported under the Open Payments program if they are made by applicable manufacturers to physicians or teaching hospitals, and must be associated with a legitimate purpose such as education or research.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• travel-expenses
• drug-marketing
• medical-education
• pulmonology
• prostate-cancer-treatment

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $2.2K payment for?

This was a travel payment of $2.2K from Merck & Co to Maria Martinez, categorized as "Travel and Lodging". It was associated with Xtandi. The payment was reported under the Sunshine Act (CMS Open Payments).

Does Maria Martinez accept pharmaceutical money?

Yes, Maria Martinez received this $2.2K payment from Merck & Co. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Maria Martinez's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $2.2K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Pulmonology?

To compare this payment against Pulmonology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Pulmonology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Maria Martinez's relationship with Merck & Co?

The payment covers travel and lodging, which can be legitimate expenses for educational or research purposes. This $2.2K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Pulmonology?

The amount is substantial, warranting scrutiny to ensure it aligns with fair market value for the services provided.

What should patients do after learning about this payment?

If you received travel or lodging payments from a pharmaceutical company, ensure these expenses were for legitimate educational or research activities and not for personal benefit.

What else should I know about this travel payment?

The payment is linked to a specific drug, Xtandi, which is common in pharmaceutical industry interactions.

Related Reports

• View Dr. Maria Martinez's full payment report
• Merck & Co full spending report
• Browse all Pulmonology payments
• Browse all payments in New York
• Search for other payments